Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2328)	4/1/2008 10:45:06 AM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

ALTH Has continued on its near term UT after if found support at the $4.90 level in mid March. The stock is up 10.20% on volume of 163,077 which is about half its ADV bigcharts.marketwatch.com But ALTH has plenty of resistance at the $7 level before it can test its Jan11-Jan17 double top at the $7.70 level.<g> bigcharts.marketwatch.com On Jan 7 it announced that it had started enrollment in a PIIb, comparing PDX & Tarceva in patients with Stage IIIB/IV NSCLC. Bernard